RDNT logo

RadNet (RDNT)

Profile

Full Name

RadNet, Inc.

Ticker Symbol

RDNT

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

January 3, 1997

Indexes

Not included

Website

http://www.radnet.com

Employees

8546

Key Details

Price

$50.26(-0.38%)

Market cap

$3.72B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.83B(+13.18% YoY)

Annual EPS

$0.04(-20.00% YoY)

PE ratio

1256.50

Next earnings date

May 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$50.26
RDNT price is $50.26

30-Day Relative Volume

0.63
RDNT 30-day relative volume is 0.63

Price Performance

Price Most recent change

-0.38%
RDNT price was down -0.38% on Apr 25, 2025

Price YTD change

-28.04%
RDNT price is down -28.04% since January 1st

Price 1-year change

+2.89%
RDNT price is up +2.89% year-on-year

Price 3-year change

+144.93%
RDNT price is up +144.93% over the past 3 years

Price Range

Price All-time high

$93.65
RDNT price is currently -46.33% below its historical high of $93.65

Price 3-year low

$12.03
RDNT price is currently +317.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.72B
RDNT market capitalization is $3.72 billion

Market cap 3-year change

+222.71%
RDNT market capitalization is up +222.71% over the past 3 years

Market cap All-time high

$6.38B
RDNT market capitalization is currently -41.70% below its historical high of $6.38 billion

Market cap sector rank

87.9%
RDNT market capitalization is higher than 87.9% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.2%
RDNT shares outstanding is up +0.2% year-on-year

Shares Outstanding 3-Year Change

+31.75%
RDNT shares outstanding is up +31.75% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.15
RDNT beta is 1.15

200-day SMA

$64.31
RDNT price is currently -21.85% below its 200-day simple moving average

50-day SMA

$52.39
RDNT price is currently -4.06% below its 50-day simple moving average

RSI

47.85
RDNT 14-day relative strength index is 47.85

Volume

0.63
RDNT 30-day relative volume is 0.63

ATR

$2.51
RDNT average true range is $2.51

10-day Historical Volatility

41.71%
RDNT 10-day historical volatility is 41.71%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.83B
RDNT annual revenue is $1.83 billion

Revenue Analysts estimate

$1.93B
RDNT annual revenue is currently -5.08% lower than the consensus analysts' forecast

Revenue 1-year change

+13.18%
RDNT annual revenue is up +13.18% year-on-year

Revenue Sector rank

84.07%
RDNT annual revenue is higher than 84.07% of companies in Healthcare sector

EPS

EPS

$0.04
RDNT annual earnings per share is $0.04

EPS Analysts estimate

$0.42
RDNT annual earnings per share is currently -90.46% lower than the consensus analysts' forecast

EPS 1-year change

-20%
RDNT annual earnings per share is down -20% year-on-year

EPS Sector rank

82.72%
RDNT annual earnings per share is higher than 82.72% of companies in Healthcare sector

Profit

Gross profit

$249.12M
RDNT annual gross profit is $249.12 million

Gross margin

13.62%
RDNT annual gross profit margin is 13.62%

Operating profit

$111.28M
RDNT annual operating income is $111.28 million

Operating margin

6.08%
RDNT annual operating profit margin is 6.08%

Net income

$2.79M
RDNT annual net profit is $2.79 million

Net margin

0.15%
RDNT annual net profit margin is 0.15%

Expenses

Total expenses

$1.72B
RDNT annual total expenses is $1.72 billion

Operating expenses

$137.84M
RDNT annual total operating expenses is $137.84 million

Cost of goods sold

$1.58B
RDNT annual cost of goods sold is $1.58 billion

Selling, general & administrative expenses

-
RDNT annual SGA value is unknown

Depreciation and amortization

$198.39M
RDNT annual depreciation & amortization is $198.39 million

Interest expense

$79.85M
RDNT annual interest expense is $79.85 million

Income tax

$6.03M
RDNT annual income tax is $6.03 million

EBIT & EBITDA

EBIT

$124.71M
RDNT annual earnings before interest & taxes is $124.71 million

EBITDA

$323.10M
RDNT annual EBITDA is $323.10 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.29B
RDNT annual total assets is $3.29 billion

Non current assets

$2.27B
RDNT annual long term assets is $2.27 billion

Current assets

$1.02B
RDNT annual total current assets is $1.02 billion

Cash and cash equivalents

$740.02M
RDNT annual cash & cash equivalents is $740.02 million

Accounts receivable

$185.82M
RDNT annual accounts receivable is $185.82 million

Inventory

-
RDNT annual inventory value is unknown

Liabilities

Total liabilities

$2.15B
RDNT annual total liabilities is $2.15 billion

Long term liabilities

$1.67B
RDNT annual total long term liabilities is $1.67 billion

Current liabilities

$479.71M
RDNT annual total current liabilities is $479.71 million

Accounts payable

$96.45M
RDNT annual accounts payable is $96.45 million

Debt

Total debt

$1.73B
RDNT annual total debt is $1.73 billion

Total debt 1-year change

+15.94%
RDNT annual total debt is up +15.94% year-on-year

Long term debt

$1.65B
RDNT annual long term debt is $1.65 billion

Short term debt

$81.31M
RDNT annual short term debt is $81.31 million

Equity & Capital

Shareholders equity

$902.31M
RDNT annual stockholders equity is $902.31 million

Book value

$902.31M
RDNT annual book value is $902.31 million

Retained earnings

-$76.78M
RDNT annual retained earnings is -$76.78 million

Working capital

$539.54M
RDNT annual working capital is $539.54 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$233.02M
RDNT annual cash flow from operations is $233.02 million

Cash from operations 1-year change

+5.51%
RDNT annual cash flow from operations is up +5.51% year-on-year

Cash from investing

-$233.07M
RDNT annual cash flow from investing activities is -$233.07 million

Cash from investing 1-year change

-15.68%
RDNT annual cash flow from investing activities is down -15.68% year-on-year

Cash from financing

$397.95M
RDNT annual cash flow from financing activities is $397.95 million

Cash from financing 1-year change

+103.41%
RDNT annual cash flow from financing activities is up +103.41% year-on-year

CAPEX

CAPEX

$231.73M
RDNT annual capital expenditures is $231.73 million

CAPEX 1-year change

+23.58%
RDNT annual capital expenditures is up +23.58% year-on-year

Free Cash Flow

Free cash flow

$1.29M
RDNT annual free cash flow is $1.29 million

Free cash flow 1-year change

-96.13%
RDNT annual free cash flow is down -96.13% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

13.62%
RDNT annual gross profit margin is 13.62%

Operating margin

6.08%
RDNT annual operating profit margin is 6.08%

Net margin

0.15%
RDNT annual net profit margin is 0.15%

ROA & ROE

ROA

0.09%
RDNT annual return on assets is 0.09%

ROE

0.29%
RDNT annual return on equity is 0.29%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

1256.50
RDNT price to earnings ratio is 1256.50

PE ratio Sector rank

100%
RDNT price to earnings ratio is higher than 100% of companies in Healthcare sector

PB Ratio

PB ratio

4.12
RDNT price to book ratio is 4.12

PB ratio Sector rank

79.07%
RDNT price to book ratio is higher than 79.07% of companies in Healthcare sector

PS Ratio

PS ratio

2.03
RDNT price to sales ratio is 2.03

PS ratio Sector rank

42.21%
RDNT price to sales ratio is higher than 42.21% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.71B
RDNT enterprise value is $4.71 billion

Enterprise value Sector rank

87.57%
RDNT enterprise value is higher than 87.57% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

13.96
RDNT EV/EBITDA is 13.96

EV/EBITDA Sector rank

86.98%
RDNT EV/EBITDA is higher than 86.98% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.12
RDNT annual current ratio is 2.12

Quick ratio

-
RDNT annual quick ratio value is unknown

Leverage

Debt to equity

1.13
RDNT annual debt to equity ratio is 1.13

Interest coverage ratio

1.56
RDNT annual interest coverage ratio is 1.56

Risk & Stability

Piotroski F-Score

5
RDNT piotroski f-score is 5

Altman Z-Score

1.88
RDNT altman z-score is 1.88

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Buy
Mar 24, 25 Barclays
Overweight
Mar 5, 25 Raymond James
Strong Buy
Jan 22, 25 Truist Securities
Buy
Jan 22, 25 Barclays
Overweight
Jan 15, 25 Jefferies
Buy
Dec 5, 24 Jefferies
Buy
Dec 4, 24 Barclays
Overweight
Nov 29, 24 Truist Securities
Buy
Sep 23, 24 Truist Securities
Buy

Institutional Ownership

Similar stocks

RNA logo
Avidity Biosciences (RNA)
PTCT logo
PTC Therapeutics (PTCT)
RARE logo
Ultragenyx Pharmaceutical (RARE)
ACLX logo
Arcellx (ACLX)
ZLAB logo
Zai Lab Limited (ZLAB)
PBH logo
Prestige Consumer Healthcare (PBH)
PRGO logo
Perrigo (PRGO)
RYTM logo
Rhythm Pharmaceuticals (RYTM)
ALHC logo
Alignment Healthcare (ALHC)
  • What is the ticker symbol for RadNet?
  • Does RadNet pay dividends?
  • What sector is RadNet in?
  • What industry is RadNet in?
  • What country is RadNet based in?
  • When did RadNet go public?
  • Is RadNet in the S&P 500?
  • Is RadNet in the NASDAQ 100?
  • Is RadNet in the Dow Jones?
  • When was RadNet's last earnings report?
  • When does RadNet report earnings?
  • Should I buy RadNet stock now?

What is the ticker symbol for RadNet?

The ticker symbol for RadNet is NASDAQ:RDNT

Does RadNet pay dividends?

No, RadNet does not pay dividends

What sector is RadNet in?

RadNet is in the Healthcare sector

What industry is RadNet in?

RadNet is in the Diagnostics & Research industry

What country is RadNet based in?

RadNet is headquartered in United States

When did RadNet go public?

RadNet's initial public offering (IPO) was on January 3, 1997

Is RadNet in the S&P 500?

No, RadNet is not included in the S&P 500 index

Is RadNet in the NASDAQ 100?

No, RadNet is not included in the NASDAQ 100 index

Is RadNet in the Dow Jones?

No, RadNet is not included in the Dow Jones index

When was RadNet's last earnings report?

RadNet's most recent earnings report was on Feb 28, 2025

When does RadNet report earnings?

The next expected earnings date for RadNet is May 12, 2025

Should I buy RadNet stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page